Natasha Giordano's Net Worth

$1.06 Million

Estimate Recalculated Apr 10, 2025 08:46PM EST

Who is Natasha Giordano

Natasha Giordano has an estimated net worth of $1.06 Million. This is based on reported shares across multiple companies, which include Matinas BioPharma Holdings, Inc., PLx Pharma Inc., ACETO CORP, Healthcare Corp of America, and DENDRITE INTERNATIONAL INC.

SEC CIK

Natasha Giordano's CIK is 0001315585

Past Insider Trading and Trends

2005 was Natasha Giordano's most active year for acquiring shares with 13 total transactions. Natasha Giordano's most active month to acquire stocks was the month of July. 2007 was Natasha Giordano's most active year for disposing of shares, totalling 10 transactions. Natasha Giordano's most active month to dispose stocks was the month of April. 2005 saw Natasha Giordano paying a total of $191,325.37 for 92,234 shares, this is the most they've acquired in one year. In 2007 Natasha Giordano cashed out on 257,286 shares for a total of $1,871,023.51, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Matinas BioPharma Holdings, Inc.

Investor
Updated Nov 03, 2023
Form 4
437.24K
Nov 03, 2023
437.24K
Grant
Nov 01
Form 4
142.66K
Nov 16, 2022
142.66K
Grant
Nov 14
Form 4
90.88K
Nov 02, 2021
90.88K
Grant
Nov 01
Form 3
Sep 15, 2020
Showing 4 results

PLx Pharma Inc.

Chief Executive Officer
Updated Mar 16, 2022
Form 4
377.53%
4.10K
$3.65
$14.98K
Mar 16, 2022
5.19K
Purchase
Mar 15
Form 4
300.00K
Feb 24, 2022
300.00K
Grant
Feb 22
Form 4
200.00K
Aug 11, 2021
200.00K
Grant
Aug 09
Form 4
350.00K
Nov 20, 2020
350.00K
Grant
Nov 18
Form 4
175.00K
Mar 24, 2020
175.00K
Grant
Mar 20
Form 4
211.68K
Mar 18, 2019
211.68K
Grant
Mar 14
Form 4
86.87K
Aug 14, 2017
86.87K
Grant
Aug 11
Form 4
217.67K
Apr 20, 2017
217.67K
Grant
Apr 19
Form 3
Apr 20, 2017
Showing 9 results

ACETO CORP

Investor
Updated Oct 03, 2019
Form 4
-100.00%
-20.97K
Oct 03, 2019
Disposition
Oct 01
Form 4
47.33%
6.74K
$10.39
$70.00K
Dec 11, 2017
20.97K
Grant
Dec 07
Form 4
32.20%
3.47K
$20.19
$70.00K
Dec 05, 2016
14.24K
Grant
Dec 01
Form 4
33.65%
2.71K
$25.82
$70.00K
Dec 16, 2015
10.77K
Grant
Dec 15
Form 4
-21.17%
-2.16K
$20.92
-$45.28K
Mar 05, 2015
8.06K
Sale
Mar 04
Form 4
26.94%
2.17K
$22.13
$48.00K
Dec 05, 2014
10.22K
Grant
Dec 04
Form 4
-15.29%
-1.45K
$21.94
-$31.88K
Sep 09, 2014
8.05K
Sale
Sep 09
Form 4
-10.88%
-1.16K
$17.28
-$20.04K
Jun 06, 2014
9.51K
Sale
Jun 06
Form 4
-9.73%
-1.15K
$17.43
-$20.03K
Jun 04, 2014
10.67K
Sale
Jun 02
Form 4
-8.72%
-1.13K
$17.91
-$20.20K
May 27, 2014
11.81K
Sale
May 23
Form 4
-7.90%
-1.11K
$17.81
-$19.77K
May 21, 2014
12.94K
Sale
May 21
Form 4
18.20%
2.16K
$22.18
$48.00K
Dec 06, 2013
14.05K
Grant
Dec 05
Form 4
71.45%
4.95K
$9.69
$48.00K
Dec 10, 2012
11.89K
Grant
Dec 06
Form 4
6.93K
$6.49
$45.00K
Dec 16, 2011
6.93K
Grant
Dec 08
Form 3
Dec 16, 2011
Showing 15 results

Healthcare Corp of America

CEO and President
Updated Mar 12, 2014
Form 3
Mar 12, 2014
Showing 1 results

DENDRITE INTERNATIONAL INC

Pres., Global Business Unit
Updated May 11, 2007
Form 4
-100.00%
-253.28K
$10.42
-$1.81M
May 11, 2007
Disposition
May 09
Form 4
-5.06%
-4.00K
$15.92
-$63.76K
May 03, 2007
75.20K
Tax
May 01
Form 4
71.41%
33.00K
Jan 29, 2007
79.21K
Grant
Jan 25
Form 4
-46.40%
-40.00K
May 03, 2006
46.21K
Grant
May 01
Form 4
-8.69%
-591.00
$12.57
-$7.43K
Apr 27, 2006
6.21K
Tax
Apr 25
Form 4
42.88%
13.47K
$15.63
-$38.15K
Aug 16, 2005
44.88K
Sell-Options
Aug 12
Form 4
60.00K
May 20, 2005
60.00K
Grant
May 18
Form 4
353.33%
5.30K
Apr 27, 2005
6.80K
Grant
Apr 25
Form 3
Feb 07, 2005
1.50K
Showing 9 results